LigaChem Biosciences Inc. (KOSDAQ:141080)

South Korea flag South Korea · Delayed Price · Currency is KRW
188,200
+7,900 (4.38%)
Apr 10, 2026, 3:30 PM KST
Market Cap6.86T +75.3%
Revenue (ttm)141.55B +12.4%
Net Income-74.28B
EPS-2,042.00
Shares Out36.44M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume361,599
Average Volume432,148
Open183,700
Previous Close180,300
Day's Range178,100 - 191,000
52-Week Range92,000 - 225,000
Beta0.62
RSI49.78
Earnings DateMay 15, 2026

About LigaChem Biosciences

LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was for... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 170
Stock Exchange KOSDAQ
Ticker Symbol 141080
Full Company Profile

Financial Performance

Financial Statements